Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Compass Therapeutics Inc
(NQ:
CMPX
)
1.160
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Compass Therapeutics Inc
Compass Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 07, 2022
From
Compass Therapeutics, Inc.
Via
Business Wire
Compass Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference
November 22, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Compass Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 12, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Compass Therapeutics Announces Pricing of Approximately $125 Million Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
November 01, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Compass Therapeutics Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
November 01, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Compass Reports the Advancement of CTX-009, a Bispecific Antibody, to Phase 2a Development in Patients with Biliary Tract Cancers (BTC), and the Clearance of a Key Clinical Hurdle
November 01, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 08, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Compass Therapeutics and ABL Bio Announce Presentation of CTX-009 Clinical Data as a Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 01, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Compass Therapeutics to Present at the Citi 16th Annual Biopharma Virtual Conference
August 13, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Compass Therapeutics, Inc. to Acquire TRIGR Therapeutics, Inc.
May 13, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.